Activist Saba Capital Reduces Stake to 20.3% Amidst Proxy Battle, Sells ~$17.75M in Shares
ECAT is trading near its 52-week low of $13.36 (14% above the low).
Summary
Activist investor Saba Capital Management has decreased its ownership in BlackRock ESG Capital Allocation Term Trust to 20.3%, selling shares valued at approximately $17.75 million amidst an ongoing proxy battle.
Key Events · Ownership and Investor Activity · ECAT
-
Activist Stake Reduction
Saba Capital Management, an activist investor, has reduced its beneficial ownership in BlackRock ESG Capital Allocation Term Trust from 23.9% to 20.3% of outstanding common shares.
-
Significant Share Sales
Between April 27, 2026, and May 8, 2026, Saba Capital sold a total of 1,191,071 common shares in open market transactions, totaling approximately $17.75 million.
-
Ongoing Proxy Fight Context
This reduction occurs amidst a heated proxy battle where Saba Capital has nominated a slate of trustees to the company's board, as detailed in recent proxy filings.
Analysis · ECAT · Unknown
Activist investor Saba Capital Management has reduced its stake in BlackRock ESG Capital Allocation Term Trust from 23.9% to 20.3%, selling approximately $17.75 million worth of shares. This reduction in ownership by a key activist during an ongoing proxy fight could signal a shift in their strategy or a weakening of their campaign, potentially impacting the dynamics of the board election.
At the time of this filing, ECAT was trading at $15.25 on NYSE in the Unknown sector. The 52-week trading range was $13.36 to $17.14. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.